Your browser is unable to support new features implemented in HTML5 and CSS3 to render this site as intended. Your experience may suffer from functionality degradation but the site should remain usable. We strongly recommend the latest version of Google Chrome, OS X Safari or Mozilla Firefox. As Safari is bundled with OS X, if you are unable to upgrade to a newer version of OS X, we recommend using an open source browser. Dismiss message

IPR005708

Description

IPR005708 is a Homogentisate 1,2-dioxygenase.

<p>Alkaptonuria (AKU), a rare hereditary disorder, was the first disease to be interpreted as an inborn error of metabolism. The deficiency causes homogentisic aciduria, ochronosis, and arthritis. AKU patients are deficient for homogentisate 1,2 dioxygenase (HGD) ([ec:1.13.11.5]), the enzyme that mediates the conversion of homogentisate to maleylacetoacetate, a step in the catabolism of both tyrosine and phenylalanine. The structure of this protein shows that the enzyme forms a hexamer arrangement comprised of a dimer of trimers. The active site iron ion is coordinated near the interface between the trimers [[cite:PUB00101169], [cite:PUB00009903]].</p> <p>This group of proteins includes human HDG and homologues from eukaryotes, bacteria and some archaeal species.</p>

This description is obtained from EB-eye REST.

Associated GO terms

GO predictions are based solely on the InterPro-to-GO mappings published by EMBL-EBI, which are in turn based on the mapping of predicted domains to the InterPro dataset. The InterPro-to-GO mapping was last updated on , while the GO metadata was last updated on .

GO term Namespace Name Definition Relationships
Molecular function Homogentisate 1,2-dioxygenase activity Catalysis of the reaction: homogentisate + O(2) = 4-maleylacetoacetate + H(+).
Biological process L-phenylalanine catabolic process The chemical reactions and pathways resulting in the breakdown of phenylalanine, 2-amino-3-phenylpropanoic acid.
Biological process Tyrosine metabolic process The chemical reactions and pathways involving tyrosine, an aromatic amino acid, 2-amino-3-(4-hydroxyphenyl)propanoic acid.
Biological process Oxidation-reduction process A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.

Associated Lotus transcripts 4

Transcript Name Description Predicted domains Domain count
PREDICTED: homogentisate 1,2-dioxygenase-like [Glycine max] gi|356543235|ref|XP_003540068.1| 7
PREDICTED: homogentisate 1,2-dioxygenase-like [Glycine max] gi|356543235|ref|XP_003540068.1| 8
Homogentisate 1,2-dioxygenase; TAIR: AT5G54080.1 homogentisate 1,2-dioxygenase; Swiss-Prot: sp|Q9ZRA2|HGD_ARATH Homogentisate 1,2-dioxygenase; TrEMBL-Plants: tr|I1LSW3|I1LSW3_SOYBN Uncharacterized protein; Found in the gene: LotjaGi3g1v0044000 9
Homogentisate 1,2-dioxygenase; TAIR: AT5G54080.1 homogentisate 1,2-dioxygenase; Swiss-Prot: sp|Q9ZRA2|HGD_ARATH Homogentisate 1,2-dioxygenase; TrEMBL-Plants: tr|I1LSW3|I1LSW3_SOYBN Uncharacterized protein; Found in the gene: LotjaGi3g1v0044000 9

Co-occuring domains 1

A list of co-occurring predicted domains within the L. japonicus gene space:

Predicted domain Source Observations Saturation (%)
TIGR01015 TIGRFAM 1 25.00